Cargando…
Effectiveness of Heterologous COVID-19 Vaccine Booster in Korean Elderly Population, 2022
We conducted a cohort study to assess vaccine effectiveness (VE) of coronavirus disease 2019 vaccine combinations on severe acute respiratory syndrome coronavirus 2 critical infection and death among elderly population in Korea. From January to August 2022, VE against death for 4 doses mRNA recipien...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Academy of Medical Sciences
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186072/ https://www.ncbi.nlm.nih.gov/pubmed/37191847 http://dx.doi.org/10.3346/jkms.2023.38.e143 |
| _version_ | 1785042494415699968 |
|---|---|
| author | Park, Seon Kyeong Choe, Young June Jang, Eun Jung Kim, Ryu Kyung Lee, Sang-Won Kwon, Geun-Yong Shin, Jeeyeon Choi, Sang-Yoon Jeong, Mi Jin Park, Young-Joon |
| author_facet | Park, Seon Kyeong Choe, Young June Jang, Eun Jung Kim, Ryu Kyung Lee, Sang-Won Kwon, Geun-Yong Shin, Jeeyeon Choi, Sang-Yoon Jeong, Mi Jin Park, Young-Joon |
| author_sort | Park, Seon Kyeong |
| collection | PubMed |
| description | We conducted a cohort study to assess vaccine effectiveness (VE) of coronavirus disease 2019 vaccine combinations on severe acute respiratory syndrome coronavirus 2 critical infection and death among elderly population in Korea. From January to August 2022, VE against death for 4 doses mRNA recipients was 96.1%, whereas 1-dose viral vector + 3-dose mRNA recipients had VE of 90.8%. |
| format | Online Article Text |
| id | pubmed-10186072 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The Korean Academy of Medical Sciences |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101860722023-05-17 Effectiveness of Heterologous COVID-19 Vaccine Booster in Korean Elderly Population, 2022 Park, Seon Kyeong Choe, Young June Jang, Eun Jung Kim, Ryu Kyung Lee, Sang-Won Kwon, Geun-Yong Shin, Jeeyeon Choi, Sang-Yoon Jeong, Mi Jin Park, Young-Joon J Korean Med Sci Brief Communication We conducted a cohort study to assess vaccine effectiveness (VE) of coronavirus disease 2019 vaccine combinations on severe acute respiratory syndrome coronavirus 2 critical infection and death among elderly population in Korea. From January to August 2022, VE against death for 4 doses mRNA recipients was 96.1%, whereas 1-dose viral vector + 3-dose mRNA recipients had VE of 90.8%. The Korean Academy of Medical Sciences 2023-04-19 /pmc/articles/PMC10186072/ /pubmed/37191847 http://dx.doi.org/10.3346/jkms.2023.38.e143 Text en © 2023 The Korean Academy of Medical Sciences. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Brief Communication Park, Seon Kyeong Choe, Young June Jang, Eun Jung Kim, Ryu Kyung Lee, Sang-Won Kwon, Geun-Yong Shin, Jeeyeon Choi, Sang-Yoon Jeong, Mi Jin Park, Young-Joon Effectiveness of Heterologous COVID-19 Vaccine Booster in Korean Elderly Population, 2022 |
| title | Effectiveness of Heterologous COVID-19 Vaccine Booster in Korean Elderly Population, 2022 |
| title_full | Effectiveness of Heterologous COVID-19 Vaccine Booster in Korean Elderly Population, 2022 |
| title_fullStr | Effectiveness of Heterologous COVID-19 Vaccine Booster in Korean Elderly Population, 2022 |
| title_full_unstemmed | Effectiveness of Heterologous COVID-19 Vaccine Booster in Korean Elderly Population, 2022 |
| title_short | Effectiveness of Heterologous COVID-19 Vaccine Booster in Korean Elderly Population, 2022 |
| title_sort | effectiveness of heterologous covid-19 vaccine booster in korean elderly population, 2022 |
| topic | Brief Communication |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186072/ https://www.ncbi.nlm.nih.gov/pubmed/37191847 http://dx.doi.org/10.3346/jkms.2023.38.e143 |
| work_keys_str_mv | AT parkseonkyeong effectivenessofheterologouscovid19vaccineboosterinkoreanelderlypopulation2022 AT choeyoungjune effectivenessofheterologouscovid19vaccineboosterinkoreanelderlypopulation2022 AT jangeunjung effectivenessofheterologouscovid19vaccineboosterinkoreanelderlypopulation2022 AT kimryukyung effectivenessofheterologouscovid19vaccineboosterinkoreanelderlypopulation2022 AT leesangwon effectivenessofheterologouscovid19vaccineboosterinkoreanelderlypopulation2022 AT kwongeunyong effectivenessofheterologouscovid19vaccineboosterinkoreanelderlypopulation2022 AT shinjeeyeon effectivenessofheterologouscovid19vaccineboosterinkoreanelderlypopulation2022 AT choisangyoon effectivenessofheterologouscovid19vaccineboosterinkoreanelderlypopulation2022 AT jeongmijin effectivenessofheterologouscovid19vaccineboosterinkoreanelderlypopulation2022 AT parkyoungjoon effectivenessofheterologouscovid19vaccineboosterinkoreanelderlypopulation2022 |